Table 1.
Agent | Action | Final concentration |
---|---|---|
ODQ | Soluble guanylate cyclase inhibitor | 10 µM |
Indomethacin | Cyclooxygenase inhibitor | 5 µM |
CPTIO | Nitric oxide scavenger | 1 mM |
U-51605 | Prostacyclin synthase inhibitor (PGISi) | 10 µM |
Raloxifene | Aldehyde oxidase inhibitor | 50 nM |
Oxypurinol | Xanthine oxidase inhibitor | 100 µM |
l-NMMA | eNOS inhibitor | 300 µM |
These represent final bath concentrations required or established for maximum effect on nitrite-induced vasodilatation.
ODQ, 1H [1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one; CPTIO, carboxy-2-phenyl-4,4,5,5-tetramethyl-imidazoline-1-oxyl-3-oxide; l-NMMA, l-NG-monomethyl arginine.